bbc semaglutide How weight-loss injections are making obesity a wealth issue Popular weight-loss drugs like Ozempic

Patients taking semaglutide should contact their healthcare provider promptly if they develop symptoms suggestive of a urinary tract infection

Wegovy (semaglutide 2.4 mg) is a once-weekly subcutaneous injection licensed by the MHRA for weight management in adults and adolescents with obesity

The medication may still be fine, or it may have degraded past the point of effectiveness

Bloodwork every 2 weeks tracks glucose, insulin, and IGF-1

Monitoring symptoms, adjusting dosage, and making dietary changes are key strategies to ensure that Ozempic use is safe and effective

Combining oral semaglutide drops with other protocols Many users do not take semaglutide in isolation